Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Lupin secures tentative FDA approval for Xywav oral solution generic Global pharma leader, Lupin Limited, proudly announced its tentative approval from the United States Food and Drug Administration… byPallavi MadhirajuOctober 12, 2023